Roivant Sciences Ltd. ($ROIV)
Filing Information
| Accession Number | 0001140361-26-030107 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 30, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
600,000
Total Value
$7,760,000.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President&Immunovant CEO | Common Shares | โ | Jul 27, 2026 | Exercise/Conversion | 200,000 | $3.85 | $770,000.00 | 1,813,063 | Direct | โ | View Details | |
President&Immunovant CEO | Common Shares | โ | Jul 27, 2026 | Sale | 200,000 | $34.95 | $6,990,000.00 | 1,613,063 | Direct | โ | View Details | |
President&Immunovant CEO | Stock Option (Right to Buy) | Derivative | Jul 27, 2026 | Exercise/Conversion | 200,000 | $0.00 | $0.00 | 4,044,834 | Direct | โ | View Details |